BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang P, Wang Q, Lin Z, Yang P, Dou K, Zhang R. Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake.Onco Targets Ther. 2019;12:11751-11763. [PMID: 32021249 DOI: 10.2147/OTT.S235667] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Samec M, Mazurakova A, Lucansky V, Koklesova L, Pecova R, Pec M, Golubnitschaja O, Al-ishaq RK, Caprnda M, Gaspar L, Prosecky R, Gazdikova K, Adamek M, Büsselberg D, Kruzliak P, Kubatka P. Flavonoids Attentuate Cancer Metabolism by Modulating Redox State, lipid metabolism, and use of amino acids or ketone bodies.. [DOI: 10.21203/rs.3.rs-2273746/v1] [Reference Citation Analysis]
2 Almatroodi SA, Alsahli MA, Rahmani AH. Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways. Molecules 2022;27:5889. [PMID: 36144625 DOI: 10.3390/molecules27185889] [Reference Citation Analysis]
3 Xiong RG, Huang SY, Wu SX, Zhou DD, Yang ZJ, Saimaiti A, Zhao CN, Shang A, Zhang YJ, Gan RY, Li HB. Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. Molecules 2022;27:4523. [PMID: 35889396 DOI: 10.3390/molecules27144523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Liu Y, Nwafor E, Li Z, Wang J, Feng X, Li H, Jia B, Ma H, He J, Pi J, Liu Z. Effects of Berberine on Liver Cancer. Natural Product Communications 2022;17:1934578X2211020. [DOI: 10.1177/1934578x221102032] [Reference Citation Analysis]
5 Chen J, Wang H, Zhou L, Liu Z, Chen H, Tan X. A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma. Cancer Med 2022. [PMID: 35560794 DOI: 10.1002/cam4.4812] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Li K, Xiao K, Zhu S, Wang Y, Wang W. Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges. Front Pharmacol 2022;13:889799. [DOI: 10.3389/fphar.2022.889799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhu Y, Xie N, Chai Y, Nie Y, Liu K, Liu Y, Yang Y, Su J, Zhang C. Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer. Front Pharmacol 2022;13:803717. [PMID: 35153781 DOI: 10.3389/fphar.2022.803717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Li X, Yu H, Gong Y, Wu P, Feng Q, Liu C. Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms. J Ethnopharmacol 2022;284:114801. [PMID: 34748868 DOI: 10.1016/j.jep.2021.114801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, Hao H, Xiong J. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B 2022;12:558-80. [PMID: 35256934 DOI: 10.1016/j.apsb.2021.09.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 28.0] [Reference Citation Analysis]
10 Tilaoui M, Ait Mouse H, Zyad A. Update and New Insights on Future Cancer Drug Candidates From Plant-Based Alkaloids. Front Pharmacol 2021;12:719694. [PMID: 34975465 DOI: 10.3389/fphar.2021.719694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emran TB, Mitra S, Khan Z, Alhumaydhi FA, Aljohani ASM, Khan I, Rahman MM, Jeandet P, Gondal TA. Berberine as a Potential Anticancer Agent: A Comprehensive Review. Molecules 2021;26:7368. [PMID: 34885950 DOI: 10.3390/molecules26237368] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 32.0] [Reference Citation Analysis]
12 Li Y, Zou L, Liu X, Luo J, Liu H. Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:760079. [PMID: 34796177 DOI: 10.3389/fcell.2021.760079] [Reference Citation Analysis]
13 Wang J, Han K, Zhang C, Chen X, Li Y, Zhu L, Luo T. Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients. J Gastrointest Oncol 2021;12:2345-60. [PMID: 34790397 DOI: 10.21037/jgo-21-237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jain D, Murti Y, Khan WU, Hossain R, Hossain MN, Agrawal KK, Ashraf RA, Islam MT, Janmeda P, Taheri Y, Alshehri MM, Daştan SD, Yeskaliyeva B, Kipchakbayeva A, Sharifi-Rad J, Cho WC. Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma. Oxid Med Cell Longev 2021;2021:9068850. [PMID: 34754365 DOI: 10.1155/2021/9068850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 He Y, Mai C, Pan H, Liu L, Zhou H, Xie Y. Targeting immunometabolism by active ingredients derived from traditional Chinese medicines for treatment of rheumatoid arthritis. Chinese Herbal Medicines 2021;13:451-60. [DOI: 10.1016/j.chmed.2021.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Yang X, Zhao Z, Fan Q, Li H, Zhao L, Liu C, Liang X. Cholesterol metabolism is decreased in patients with diminished ovarian reserve. Reprod Biomed Online 2021:S1472-6483(21)00472-7. [PMID: 34801402 DOI: 10.1016/j.rbmo.2021.09.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wu J, Xue R, Jiang RT, Meng QH. Characterization of metabolic landscape in hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(9): 1144-1156 [PMID: 34616519 DOI: 10.4251/wjgo.v13.i9.1144] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gao J, Yin Z, Wu Z, Sheng Z, Ma C, Chen R, Zhang X, Tang K, Fei J, Cao Z. Probing Synergistic Targets by Natural Compounds for Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:715762. [PMID: 34395446 DOI: 10.3389/fcell.2021.715762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Warowicka A, Qasem B, Dera-Szymanowska A, Wołuń-Cholewa M, Florczak P, Horst N, Napierała M, Szymanowski K, Popenda Ł, Bartkowiak G, Florek E, Goździcka-Józefiak A, Młynarz P. Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression. Pharmaceutics 2021;13:931. [PMID: 34201532 DOI: 10.3390/pharmaceutics13070931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wang K, Yu G, Lin J, Wang Z, Lu Q, Gu C, Yang T, Liu S, Yang H. Berberine Sensitizes Human Hepatoma Cells to Regorafenib via Modulating Expression of Circular RNAs. Front Pharmacol 2021;12:632201. [PMID: 34220494 DOI: 10.3389/fphar.2021.632201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Zhou X, Liu C, Zeng H, Wu D, Liu L. Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma. Biosci Rep 2021;41:BSR20202870. [PMID: 33835133 DOI: 10.1042/BSR20202870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sun Z, Tan Z, Peng C, Yi W. HK2 is associated with the Warburg effect and proliferation in liver cancer: Targets for effective therapy with glycyrrhizin. Mol Med Rep 2021;23:343. [PMID: 33760124 DOI: 10.3892/mmr.2021.11982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Koltai T, Reshkin SJ, Baltazar F, Fliegel L. Glutamine metabolism in prostate cancer. Prostate Cancer Metabolism 2021. [DOI: 10.1016/b978-0-323-90528-2.00001-1] [Reference Citation Analysis]
24 Li J, Zou Y, Pei M, Zhang Y, Jiang Y. Berberine inhibits the Warburg effect through TET3/miR-145/HK2 pathways in ovarian cancer cells. J Cancer 2021;12:207-16. [PMID: 33391417 DOI: 10.7150/jca.48896] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]